Nisa Investment Advisors, LLC Tg Therapeutics, Inc. Transaction History

Nisa Investment Advisors, LLC

$24.1 Billion
Q4 2024

A detailed history of Nisa Investment Advisors, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 8,112 shares of TGTX stock, worth $323,344. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,112

Previous 5,309 52.8%

Holding current value

$323,344

Previous $124,000 96.77%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 17, 2025	BUY	$21.31 - $35.09 $59,731 - $98,357	2,803 Added 52.8%	8,112 $244,000
Q3 2024 Oct 24, 2024	SELL	$17.21 - $25.28 $1,893 - $2,780	-110 Reduced 2.03%	5,309 $124,000
Q2 2024 Jul 19, 2024	BUY	$13.32 - $19.19 $1,371 - $1,976	103 Added 1.94%	5,419 $96,000
Q1 2024 May 01, 2024	BUY	$13.02 - $21.3 $1,770 - $2,896	136 Added 2.63%	5,316 $80,000
Q4 2023 Jan 25, 2024	SELL	$6.68 - $18.81 $301,268 - $848,331	-45,100 Reduced 89.7%	5,180 $88,000
Q3 2023 Nov 02, 2023	SELL	$8.36 - $26.5 $299,288 - $948,700	-35,800 Reduced 41.59%	50,280 $420,000
Q2 2023 Aug 11, 2023	SELL	$15.48 - $35.0 $312,696 - $707,000	-20,200 Reduced 19.01%	86,080 $2.14 Million
Q1 2023 May 02, 2023	BUY	$10.23 - $19.34 $314,674 - $594,898	30,760 Added 40.73%	106,280 $1.6 Million
Q4 2022 Feb 02, 2023	BUY	$5.01 - $11.83 $327,153 - $772,499	65,300 Added 638.94%	75,520 $893,000
Q3 2022 Nov 07, 2022	BUY	$4.57 - $8.4 $40,988 - $75,339	8,969 Added 716.95%	10,220 $59,000
Q2 2022 Aug 03, 2022	SELL	$3.74 - $10.66 $278,256 - $793,104	-74,400 Reduced 98.35%	1,251 $5,000
Q1 2022 Apr 29, 2022	BUY	$7.81 - $20.45 $444,389 - $1.16 Million	56,900 Added 303.45%	75,651 $719,000
Q4 2021 Feb 03, 2022	SELL	$15.2 - $35.51 $121,083 - $282,872	-7,966 Reduced 29.82%	18,751 $217,000
Q3 2021 Oct 18, 2021	BUY	$21.78 - $40.45 $1,350 - $2,507	62 Added 0.23%	26,717 $889,000
Q2 2021 Aug 06, 2021	BUY	$32.5 - $48.96 $9,750 - $14,688	300 Added 1.14%	26,655 $1.03 Million
Q1 2021 Apr 26, 2021	SELL	$41.61 - $54.3 $8,946 - $11,674	-215 Reduced 0.81%	26,355 $1.27 Million
Q4 2020 Jan 25, 2021	BUY	$25.27 - $54.9 $139,490 - $303,048	5,520 Added 26.22%	26,570 $1.38 Million
Q3 2020 Oct 20, 2020	BUY	$18.49 - $27.24 $49,922 - $73,548	2,700 Added 14.71%	21,050 $563,000
Q1 2020 Apr 17, 2020	SELL	$7.14 - $15.99 $535 - $1,199	-75 Reduced 0.41%	18,350 $181,000
Q4 2018 Jan 17, 2019	BUY	$3.44 - $5.76 $60,200 - $100,800	17,500 Added 1891.89%	18,425 $76,000
Q2 2018 Jul 19, 2018	BUY	$12.5 - $15.0 $5,000 - $6,000	400 Added 76.19%	925 $12,000
Q1 2018 Apr 10, 2018	SELL	$8.7 - $16.8 $5,872 - $11,340	-675 Reduced 56.25%	525 $7,000
Q4 2017 Jan 12, 2018	BUY	$7.35 - $12.3 $1,470 - $2,460	200 Added 20.0%	1,200 $10,000
Q3 2017 Oct 13, 2017	BUY	$10.0 - $12.7 $10,000 - $12,700	1,000	1,000 $12,000

Others Institutions Holding TGTX

# of Institutions

372

Shares Held

85.5M

Call Options Held

3.78M

Put Options Held

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $5.79B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Account

Nisa Investment Advisors, LLC Tg Therapeutics, Inc. Transaction History